LAURENT PHARMACEUTICALS INC. — Form D/A
LAURENT PHARMACEUTICALS INC. of MONTREAL, A8, a company, filed a Form D amendment with the SEC on 2020-05-29. $1.9M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2020-05-29
- Form: D/A
- Accession: 0000899797-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Amount sold: $1.9M
- Minimum investment: $25K
- Investors: 42
- Date of first sale: 2018-09-05
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-321728
Issuer
- Name: LAURENT PHARMACEUTICALS INC.
- CIK: 0001752986
- Entity type: Corporation
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Address: 1010 SHERBROOKE ST. WEST, MONTREAL, A8, H3A 2R7
- Phone: 514-513-2252
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| FRANCOIS CRISTIAN MONGRAIN | Director | MONTREAL, A8 |
| YVES CRISTIAN ROSCONI | Director | MONTREAL, A8 |
| RADU CRISTIAN PISLARIU | Director | MONTREAL, A8 |
| RADU CRISTIAN PISLARIU | Executive Officer | MONTREAL, A8 |
Other filings by this issuer (6)
More